Assessment of Quality of Life and Therapeutic Outcomes of Metformin, Pioglitazone with Myoinositol and Ethinylestradiol Cyproterone in Ethnic Pakistani Women with Polycystic Ovary Syndrome

    January 2019
    Azhar Ali Khan
    Studysummary In this study, metformin, pioglitazone, and ethinylestradiol cyproterone all improved various clinical features and quality of life in Pakistani women with PCOS, though no drug significantly reduced hirsutism.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on reproductive-endocrinology-infertility.imedpub.com →
    Discuss this study in the Community →

    Related research 5

    1. Reproductive Hormone Levels and Metabolic Syndrome in Women with Polycystic Ovary Syndrome in Sana'a, Yemen Universal Journal of Pharmaceutical Research · 2021
    2. Prevalence of Polycystic Ovarian Syndrome in Young Adult Unmarried Females Attending Zagazig University Hospital Outpatient Clinic The Egyptian Journal of Hospital Medicine · 2020
    3. The Impact of Polycystic Ovary Syndrome on Women’s Quality of Life: Nursing Guidelines Clinical nursing studies · 2019
    4. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome Journal of Womens Health · 2018
    5. Observational Study on Risk Factors, Complications, and Management of Polycystic Ovarian Syndrome Deleted Journal · 2018